company_name,company_ticker,company_lei,company_cik,year,quarter,start_date,end_date,filing_date,parent,tag,financial_name,factor,balance,unit,value
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 11:14:54+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,354740000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 11:14:54+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,354740000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 11:14:54+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,215151000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 11:14:54+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,215151000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 11:14:54+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,139589000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 11:14:54+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,60839000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 11:14:54+00:00,totaloperatingexpenses,depreciationexpense,Depreciation Expense,+,debit,usd,24638000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 11:14:54+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,43388000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 11:14:54+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,128865000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 11:14:54+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,10724000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 11:14:54+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1384000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 11:14:54+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-21766000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 11:14:54+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-3771000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 11:14:54+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-26921000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 11:14:54+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-16197000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 11:14:54+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-6333000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 11:14:54+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,-177000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 11:14:54+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-10041000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 11:14:54+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-10041000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 11:14:54+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-10041000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 11:14:54+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,40268000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 11:14:54+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.25
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 11:14:54+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,40268000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 11:14:54+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.25
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 11:14:54+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,40200000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 11:14:54+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.25
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2014.0,Q2,2014-04-01,2014-06-30,2015-07-28 11:20:13+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,357545000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2014.0,Q2,2014-04-01,2014-06-30,2015-07-28 11:20:13+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,357545000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2014.0,Q2,2014-04-01,2014-06-30,2015-07-28 11:20:13+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,213378000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2014.0,Q2,2014-04-01,2014-06-30,2015-07-28 11:20:13+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,213378000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2014.0,Q2,2014-04-01,2014-06-30,2015-07-28 11:20:13+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,144167000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2014.0,Q2,2014-04-01,2014-06-30,2015-07-28 11:20:13+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,56010000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2014.0,Q2,2014-04-01,2014-06-30,2015-07-28 11:20:13+00:00,totaloperatingexpenses,depreciationexpense,Depreciation Expense,+,debit,usd,24598000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2014.0,Q2,2014-04-01,2014-06-30,2015-07-28 11:20:13+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,46123000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2014.0,Q2,2014-04-01,2014-06-30,2015-07-28 11:20:13+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,0.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2014.0,Q2,2014-04-01,2014-06-30,2015-07-28 11:20:13+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,126731000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2014.0,Q2,2014-04-01,2014-06-30,2015-07-28 11:20:13+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,17436000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2014.0,Q2,2014-04-01,2014-06-30,2015-07-28 11:20:13+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,0.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2014.0,Q2,2014-04-01,2014-06-30,2015-07-28 11:20:13+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-20818000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2014.0,Q2,2014-04-01,2014-06-30,2015-07-28 11:20:13+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-5503000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2014.0,Q2,2014-04-01,2014-06-30,2015-07-28 11:20:13+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-26321000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2014.0,Q2,2014-04-01,2014-06-30,2015-07-28 11:20:13+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-8885000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2014.0,Q2,2014-04-01,2014-06-30,2015-07-28 11:20:13+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-5186000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2014.0,Q2,2014-04-01,2014-06-30,2015-07-28 11:20:13+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,-357000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2014.0,Q2,2014-04-01,2014-06-30,2015-07-28 11:20:13+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-4056000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2014.0,Q2,2014-04-01,2014-06-30,2015-07-28 11:20:13+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-4056000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2014.0,Q2,2014-04-01,2014-06-30,2015-07-28 11:20:13+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-4056000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2014.0,Q2,2014-04-01,2014-06-30,2015-07-28 11:20:13+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,40268000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2014.0,Q2,2014-04-01,2014-06-30,2015-07-28 11:20:13+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.1
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2014.0,Q2,2014-04-01,2014-06-30,2015-07-28 11:20:13+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,40268000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2014.0,Q2,2014-04-01,2014-06-30,2015-07-28 11:20:13+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.1
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2014.0,Q2,2014-04-01,2014-06-30,2015-07-28 11:20:13+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,40600000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2014.0,Q2,2014-04-01,2014-06-30,2015-07-28 11:20:13+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.1
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2014.0,Q3,2014-07-01,2014-09-30,2015-11-03 10:18:07+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,377337000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2014.0,Q3,2014-07-01,2014-09-30,2015-11-03 10:18:07+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,377337000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2014.0,Q3,2014-07-01,2014-09-30,2015-11-03 10:18:07+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,215746000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2014.0,Q3,2014-07-01,2014-09-30,2015-11-03 10:18:07+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,215746000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2014.0,Q3,2014-07-01,2014-09-30,2015-11-03 10:18:07+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,161591000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2014.0,Q3,2014-07-01,2014-09-30,2015-11-03 10:18:07+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,63432000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2014.0,Q3,2014-07-01,2014-09-30,2015-11-03 10:18:07+00:00,totaloperatingexpenses,depreciationexpense,Depreciation Expense,+,debit,usd,23903000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2014.0,Q3,2014-07-01,2014-09-30,2015-11-03 10:18:07+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,57274000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2014.0,Q3,2014-07-01,2014-09-30,2015-11-03 10:18:07+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,8000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2014.0,Q3,2014-07-01,2014-09-30,2015-11-03 10:18:07+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,144617000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2014.0,Q3,2014-07-01,2014-09-30,2015-11-03 10:18:07+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,16974000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2014.0,Q3,2014-07-01,2014-09-30,2015-11-03 10:18:07+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,0.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2014.0,Q3,2014-07-01,2014-09-30,2015-11-03 10:18:07+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-21026000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2014.0,Q3,2014-07-01,2014-09-30,2015-11-03 10:18:07+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,10600000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2014.0,Q3,2014-07-01,2014-09-30,2015-11-03 10:18:07+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-10426000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2014.0,Q3,2014-07-01,2014-09-30,2015-11-03 10:18:07+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,6548000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2014.0,Q3,2014-07-01,2014-09-30,2015-11-03 10:18:07+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,4899000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2014.0,Q3,2014-07-01,2014-09-30,2015-11-03 10:18:07+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,-474000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2014.0,Q3,2014-07-01,2014-09-30,2015-11-03 10:18:07+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1175000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2014.0,Q3,2014-07-01,2014-09-30,2015-11-03 10:18:07+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1175000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2014.0,Q3,2014-07-01,2014-09-30,2015-11-03 10:18:07+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1175000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2014.0,Q3,2014-07-01,2014-09-30,2015-11-03 10:18:07+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,40284000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2014.0,Q3,2014-07-01,2014-09-30,2015-11-03 10:18:07+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.03
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2014.0,Q3,2014-07-01,2014-09-30,2015-11-03 10:18:07+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,42072000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2014.0,Q3,2014-07-01,2014-09-30,2015-11-03 10:18:07+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.03
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2014.0,Q3,2014-07-01,2014-09-30,2015-11-03 10:18:07+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,39200000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2014.0,Q3,2014-07-01,2014-09-30,2015-11-03 10:18:07+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.03
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2014.0,Q4,2014-10-01,2014-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,369964000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2014.0,Q4,2014-10-01,2014-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,369964000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2014.0,Q4,2014-10-01,2014-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,214943000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2014.0,Q4,2014-10-01,2014-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,214943000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,155021000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,73689000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingexpenses,depreciationexpense,Depreciation Expense,+,debit,usd,23425000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,46205000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,-3000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,143316000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2014.0,Q4,2014-10-01,2014-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,11705000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2014.0,Q4,2014-10-01,2014-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,23652000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2014.0,Q4,2014-10-01,2014-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-18329000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2014.0,Q4,2014-10-01,2014-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,6958000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2014.0,Q4,2014-10-01,2014-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-35023000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2014.0,Q4,2014-10-01,2014-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-23318000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2014.0,Q4,2014-10-01,2014-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-1534000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2014.0,Q4,2014-10-01,2014-12-31,,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,-1036000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2014.0,Q4,2014-10-01,2014-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-22820000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2014.0,Q4,2014-10-01,2014-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-22820000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2014.0,Q4,2014-10-01,2014-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-22820000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2014.0,Q4,2014-10-01,2014-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,42897000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2014.0,Q4,2014-10-01,2014-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.51
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2014.0,Q4,2014-10-01,2014-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,42897000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2014.0,Q4,2014-10-01,2014-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.51
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2014.0,Q4,2014-10-01,2014-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,43100000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2014.0,Q4,2014-10-01,2014-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.51
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2015.0,Q1,2015-01-01,2015-03-31,2016-04-28 12:33:58+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,388578000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2015.0,Q1,2015-01-01,2015-03-31,2016-04-28 12:33:58+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,388578000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2015.0,Q1,2015-01-01,2015-03-31,2016-04-28 12:33:58+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,218961000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2015.0,Q1,2015-01-01,2015-03-31,2016-04-28 12:33:58+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,218961000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2015.0,Q1,2015-01-01,2015-03-31,2016-04-28 12:33:58+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,169617000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2015.0,Q1,2015-01-01,2015-03-31,2016-04-28 12:33:58+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,60835000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2015.0,Q1,2015-01-01,2015-03-31,2016-04-28 12:33:58+00:00,totaloperatingexpenses,depreciationexpense,Depreciation Expense,+,debit,usd,19235000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2015.0,Q1,2015-01-01,2015-03-31,2016-04-28 12:33:58+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,56610000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2015.0,Q1,2015-01-01,2015-03-31,2016-04-28 12:33:58+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,0.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2015.0,Q1,2015-01-01,2015-03-31,2016-04-28 12:33:58+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,136680000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2015.0,Q1,2015-01-01,2015-03-31,2016-04-28 12:33:58+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,32937000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2015.0,Q1,2015-01-01,2015-03-31,2016-04-28 12:33:58+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,0.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2015.0,Q1,2015-01-01,2015-03-31,2016-04-28 12:33:58+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-15393000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2015.0,Q1,2015-01-01,2015-03-31,2016-04-28 12:33:58+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,8602000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2015.0,Q1,2015-01-01,2015-03-31,2016-04-28 12:33:58+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-6791000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2015.0,Q1,2015-01-01,2015-03-31,2016-04-28 12:33:58+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,26146000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2015.0,Q1,2015-01-01,2015-03-31,2016-04-28 12:33:58+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,8022000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2015.0,Q1,2015-01-01,2015-03-31,2016-04-28 12:33:58+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,-937000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2015.0,Q1,2015-01-01,2015-03-31,2016-04-28 12:33:58+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,17187000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2015.0,Q1,2015-01-01,2015-03-31,2016-04-28 12:33:58+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,17187000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2015.0,Q1,2015-01-01,2015-03-31,2016-04-28 12:33:58+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,17187000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2015.0,Q1,2015-01-01,2015-03-31,2016-04-28 12:33:58+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,59815000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2015.0,Q1,2015-01-01,2015-03-31,2016-04-28 12:33:58+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.29
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2015.0,Q1,2015-01-01,2015-03-31,2016-04-28 12:33:58+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,62777000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2015.0,Q1,2015-01-01,2015-03-31,2016-04-28 12:33:58+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.27
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2015.0,Q1,2015-01-01,2015-03-31,2016-04-28 12:33:58+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,59300000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2015.0,Q1,2015-01-01,2015-03-31,2016-04-28 12:33:58+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.29
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2015.0,Q2,2015-04-01,2015-06-30,2016-07-29 11:25:13+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,392848000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2015.0,Q2,2015-04-01,2015-06-30,2016-07-29 11:25:13+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,392848000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2015.0,Q2,2015-04-01,2015-06-30,2016-07-29 11:25:13+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,219877000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2015.0,Q2,2015-04-01,2015-06-30,2016-07-29 11:25:13+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,219877000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2015.0,Q2,2015-04-01,2015-06-30,2016-07-29 11:25:13+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,172971000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2015.0,Q2,2015-04-01,2015-06-30,2016-07-29 11:25:13+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,58905000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2015.0,Q2,2015-04-01,2015-06-30,2016-07-29 11:25:13+00:00,totaloperatingexpenses,depreciationexpense,Depreciation Expense,+,debit,usd,19220000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2015.0,Q2,2015-04-01,2015-06-30,2016-07-29 11:25:13+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,56330000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2015.0,Q2,2015-04-01,2015-06-30,2016-07-29 11:25:13+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,195000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2015.0,Q2,2015-04-01,2015-06-30,2016-07-29 11:25:13+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,134650000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2015.0,Q2,2015-04-01,2015-06-30,2016-07-29 11:25:13+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,38321000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2015.0,Q2,2015-04-01,2015-06-30,2016-07-29 11:25:13+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,0.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2015.0,Q2,2015-04-01,2015-06-30,2016-07-29 11:25:13+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-15416000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2015.0,Q2,2015-04-01,2015-06-30,2016-07-29 11:25:13+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-4062000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2015.0,Q2,2015-04-01,2015-06-30,2016-07-29 11:25:13+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-19478000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2015.0,Q2,2015-04-01,2015-06-30,2016-07-29 11:25:13+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,18843000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2015.0,Q2,2015-04-01,2015-06-30,2016-07-29 11:25:13+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,5623000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2015.0,Q2,2015-04-01,2015-06-30,2016-07-29 11:25:13+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,-805000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2015.0,Q2,2015-04-01,2015-06-30,2016-07-29 11:25:13+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,12415000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2015.0,Q2,2015-04-01,2015-06-30,2016-07-29 11:25:13+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,12415000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2015.0,Q2,2015-04-01,2015-06-30,2016-07-29 11:25:13+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,12415000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2015.0,Q2,2015-04-01,2015-06-30,2016-07-29 11:25:13+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,59871000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2015.0,Q2,2015-04-01,2015-06-30,2016-07-29 11:25:13+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.21
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2015.0,Q2,2015-04-01,2015-06-30,2016-07-29 11:25:13+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,62951000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2015.0,Q2,2015-04-01,2015-06-30,2016-07-29 11:25:13+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.2
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2015.0,Q2,2015-04-01,2015-06-30,2016-07-29 11:25:13+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,59100000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2015.0,Q2,2015-04-01,2015-06-30,2016-07-29 11:25:13+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.21
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 13:36:30+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,403510000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 13:36:30+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,403510000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 13:36:30+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,212808000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 13:36:30+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,212808000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 13:36:30+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,190702000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 13:36:30+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,63091000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 13:36:30+00:00,totaloperatingexpenses,depreciationexpense,Depreciation Expense,+,debit,usd,19762000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 13:36:30+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,58414000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 13:36:30+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,256000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 13:36:30+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,141523000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 13:36:30+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,49179000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 13:36:30+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,0.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 13:36:30+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-15255000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 13:36:30+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,2750000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 13:36:30+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-12505000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 13:36:30+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,36674000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 13:36:30+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,10696000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 13:36:30+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,-2319000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 13:36:30+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,23659000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 13:36:30+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,23659000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 13:36:30+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,23659000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 13:36:30+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,60050000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 13:36:30+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.39
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 13:36:30+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,63504000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 13:36:30+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.37
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 13:36:30+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,60700000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 13:36:30+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.39
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2015.0,Q4,2015-10-01,2015-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,428947000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2015.0,Q4,2015-10-01,2015-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,428947000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2015.0,Q4,2015-10-01,2015-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,234882000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2015.0,Q4,2015-10-01,2015-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,234882000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,194065000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,63586000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingexpenses,depreciationexpense,Depreciation Expense,+,debit,usd,19735000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,66682000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,201000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,150204000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2015.0,Q4,2015-10-01,2015-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,43861000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2015.0,Q4,2015-10-01,2015-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-15683000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2015.0,Q4,2015-10-01,2015-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,5324000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2015.0,Q4,2015-10-01,2015-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-10359000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2015.0,Q4,2015-10-01,2015-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,33502000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2015.0,Q4,2015-10-01,2015-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,5663000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2015.0,Q4,2015-10-01,2015-12-31,,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,665000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2015.0,Q4,2015-10-01,2015-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,28504000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2015.0,Q4,2015-10-01,2015-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,28504000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2015.0,Q4,2015-10-01,2015-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,28504000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2015.0,Q4,2015-10-01,2015-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,59965000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2015.0,Q4,2015-10-01,2015-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.47
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2015.0,Q4,2015-10-01,2015-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,63207000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2015.0,Q4,2015-10-01,2015-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.45
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2015.0,Q4,2015-10-01,2015-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,60100000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2015.0,Q4,2015-10-01,2015-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.47
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2016.0,Q1,2016-01-01,2016-03-31,2017-04-26 13:55:58+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,430223000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2016.0,Q1,2016-01-01,2016-03-31,2017-04-26 13:55:58+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,430223000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2016.0,Q1,2016-01-01,2016-03-31,2017-04-26 13:55:58+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,243487000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2016.0,Q1,2016-01-01,2016-03-31,2017-04-26 13:55:58+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,243487000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2016.0,Q1,2016-01-01,2016-03-31,2017-04-26 13:55:58+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,186736000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2016.0,Q1,2016-01-01,2016-03-31,2017-04-26 13:55:58+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,63990000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2016.0,Q1,2016-01-01,2016-03-31,2017-04-26 13:55:58+00:00,totaloperatingexpenses,depreciationexpense,Depreciation Expense,+,debit,usd,16953000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2016.0,Q1,2016-01-01,2016-03-31,2017-04-26 13:55:58+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,86819000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2016.0,Q1,2016-01-01,2016-03-31,2017-04-26 13:55:58+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,28000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2016.0,Q1,2016-01-01,2016-03-31,2017-04-26 13:55:58+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,167790000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2016.0,Q1,2016-01-01,2016-03-31,2017-04-26 13:55:58+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,18946000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2016.0,Q1,2016-01-01,2016-03-31,2017-04-26 13:55:58+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,21485000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2016.0,Q1,2016-01-01,2016-03-31,2017-04-26 13:55:58+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-15366000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2016.0,Q1,2016-01-01,2016-03-31,2017-04-26 13:55:58+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-2790000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2016.0,Q1,2016-01-01,2016-03-31,2017-04-26 13:55:58+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-39641000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2016.0,Q1,2016-01-01,2016-03-31,2017-04-26 13:55:58+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-20695000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2016.0,Q1,2016-01-01,2016-03-31,2017-04-26 13:55:58+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-5264000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2016.0,Q1,2016-01-01,2016-03-31,2017-04-26 13:55:58+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,-538000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2016.0,Q1,2016-01-01,2016-03-31,2017-04-26 13:55:58+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-15969000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2016.0,Q1,2016-01-01,2016-03-31,2017-04-26 13:55:58+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-15969000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2016.0,Q1,2016-01-01,2016-03-31,2017-04-26 13:55:58+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-15969000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2016.0,Q1,2016-01-01,2016-03-31,2017-04-26 13:55:58+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,60199000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2016.0,Q1,2016-01-01,2016-03-31,2017-04-26 13:55:58+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.27
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2016.0,Q1,2016-01-01,2016-03-31,2017-04-26 13:55:58+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,60199000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2016.0,Q1,2016-01-01,2016-03-31,2017-04-26 13:55:58+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.27
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2016.0,Q1,2016-01-01,2016-03-31,2017-04-26 13:55:58+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,59100000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2016.0,Q1,2016-01-01,2016-03-31,2017-04-26 13:55:58+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.27
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 12:11:00+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,455847000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 12:11:00+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,455847000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 12:11:00+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,254936000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 12:11:00+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,254936000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 12:11:00+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,200911000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 12:11:00+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,68468000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 12:11:00+00:00,totaloperatingexpenses,depreciationexpense,Depreciation Expense,+,debit,usd,17585000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 12:11:00+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,64467000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 12:11:00+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,43000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 12:11:00+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,150563000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 12:11:00+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,50348000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 12:11:00+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,0.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 12:11:00+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-13380000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 12:11:00+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,10767000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 12:11:00+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-2613000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 12:11:00+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,47735000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 12:11:00+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,12312000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 12:11:00+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,3247000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 12:11:00+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,38670000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 12:11:00+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,38670000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 12:11:00+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,0.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 12:11:00+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,38670000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 12:11:00+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,60597000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 12:11:00+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.64
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 12:11:00+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,64410000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 12:11:00+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.6
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 12:11:00+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,60400000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 12:11:00+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.64
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2016.0,Q3,2016-07-01,2016-09-30,2017-10-26 10:47:28+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,453255000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2016.0,Q3,2016-07-01,2016-09-30,2017-10-26 10:47:28+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,453255000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2016.0,Q3,2016-07-01,2016-09-30,2017-10-26 10:47:28+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,259910000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2016.0,Q3,2016-07-01,2016-09-30,2017-10-26 10:47:28+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,259910000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2016.0,Q3,2016-07-01,2016-09-30,2017-10-26 10:47:28+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,193345000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2016.0,Q3,2016-07-01,2016-09-30,2017-10-26 10:47:28+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,67190000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2016.0,Q3,2016-07-01,2016-09-30,2017-10-26 10:47:28+00:00,totaloperatingexpenses,depreciationexpense,Depreciation Expense,+,debit,usd,17708000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2016.0,Q3,2016-07-01,2016-09-30,2017-10-26 10:47:28+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,53414000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2016.0,Q3,2016-07-01,2016-09-30,2017-10-26 10:47:28+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,219000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2016.0,Q3,2016-07-01,2016-09-30,2017-10-26 10:47:28+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,138531000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2016.0,Q3,2016-07-01,2016-09-30,2017-10-26 10:47:28+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,54814000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2016.0,Q3,2016-07-01,2016-09-30,2017-10-26 10:47:28+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,0.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2016.0,Q3,2016-07-01,2016-09-30,2017-10-26 10:47:28+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-13779000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2016.0,Q3,2016-07-01,2016-09-30,2017-10-26 10:47:28+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,1202000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2016.0,Q3,2016-07-01,2016-09-30,2017-10-26 10:47:28+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-12577000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2016.0,Q3,2016-07-01,2016-09-30,2017-10-26 10:47:28+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,42237000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2016.0,Q3,2016-07-01,2016-09-30,2017-10-26 10:47:28+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,10821000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2016.0,Q3,2016-07-01,2016-09-30,2017-10-26 10:47:28+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,33000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2016.0,Q3,2016-07-01,2016-09-30,2017-10-26 10:47:28+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,31449000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2016.0,Q3,2016-07-01,2016-09-30,2017-10-26 10:47:28+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,31449000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2016.0,Q3,2016-07-01,2016-09-30,2017-10-26 10:47:28+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,0.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2016.0,Q3,2016-07-01,2016-09-30,2017-10-26 10:47:28+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,31449000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2016.0,Q3,2016-07-01,2016-09-30,2017-10-26 10:47:28+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,60937000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2016.0,Q3,2016-07-01,2016-09-30,2017-10-26 10:47:28+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.52
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2016.0,Q3,2016-07-01,2016-09-30,2017-10-26 10:47:28+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,64521000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2016.0,Q3,2016-07-01,2016-09-30,2017-10-26 10:47:28+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.49
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2016.0,Q3,2016-07-01,2016-09-30,2017-10-26 10:47:28+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,60500000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2016.0,Q3,2016-07-01,2016-09-30,2017-10-26 10:47:28+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.52
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2016.0,Q4,2016-10-01,2016-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,472386000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2016.0,Q4,2016-10-01,2016-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,472386000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2016.0,Q4,2016-10-01,2016-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,506043000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2016.0,Q4,2016-10-01,2016-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,506043000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,-33657000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,70245000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingexpenses,depreciationexpense,Depreciation Expense,+,debit,usd,17260000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,-159866000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,463000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,-71898000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2016.0,Q4,2016-10-01,2016-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,38241000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2016.0,Q4,2016-10-01,2016-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,16693000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2016.0,Q4,2016-10-01,2016-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-12388000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2016.0,Q4,2016-10-01,2016-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,15457000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2016.0,Q4,2016-10-01,2016-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-13624000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2016.0,Q4,2016-10-01,2016-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,24617000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2016.0,Q4,2016-10-01,2016-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,10625000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2016.0,Q4,2016-10-01,2016-12-31,,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,33000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2016.0,Q4,2016-10-01,2016-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,14025000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2016.0,Q4,2016-10-01,2016-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,14025000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2016.0,Q4,2016-10-01,2016-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,14025000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2016.0,Q4,2016-10-01,2016-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,60759000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2016.0,Q4,2016-10-01,2016-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.23
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2016.0,Q4,2016-10-01,2016-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,64452000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2016.0,Q4,2016-10-01,2016-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.24
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2016.0,Q4,2016-10-01,2016-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,60900000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2016.0,Q4,2016-10-01,2016-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.23
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2017.0,Q1,2017-01-01,2017-03-31,2018-04-26 15:22:37+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,487760000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2017.0,Q1,2017-01-01,2017-03-31,2018-04-26 15:22:37+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,487760000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2017.0,Q1,2017-01-01,2017-03-31,2018-04-26 15:22:37+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,287512000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2017.0,Q1,2017-01-01,2017-03-31,2018-04-26 15:22:37+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,287512000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2017.0,Q1,2017-01-01,2017-03-31,2018-04-26 15:22:37+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,200248000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2017.0,Q1,2017-01-01,2017-03-31,2018-04-26 15:22:37+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,74268000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2017.0,Q1,2017-01-01,2017-03-31,2018-04-26 15:22:37+00:00,totaloperatingexpenses,depreciationexpense,Depreciation Expense,+,debit,usd,15192000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2017.0,Q1,2017-01-01,2017-03-31,2018-04-26 15:22:37+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,60720000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2017.0,Q1,2017-01-01,2017-03-31,2018-04-26 15:22:37+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,82000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2017.0,Q1,2017-01-01,2017-03-31,2018-04-26 15:22:37+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,150262000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2017.0,Q1,2017-01-01,2017-03-31,2018-04-26 15:22:37+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,49986000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2017.0,Q1,2017-01-01,2017-03-31,2018-04-26 15:22:37+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-9527000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2017.0,Q1,2017-01-01,2017-03-31,2018-04-26 15:22:37+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-7394000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2017.0,Q1,2017-01-01,2017-03-31,2018-04-26 15:22:37+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-16921000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2017.0,Q1,2017-01-01,2017-03-31,2018-04-26 15:22:37+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,33065000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2017.0,Q1,2017-01-01,2017-03-31,2018-04-26 15:22:37+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,7883000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2017.0,Q1,2017-01-01,2017-03-31,2018-04-26 15:22:37+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,42000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2017.0,Q1,2017-01-01,2017-03-31,2018-04-26 15:22:37+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,25224000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2017.0,Q1,2017-01-01,2017-03-31,2018-04-26 15:22:37+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,25224000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2017.0,Q1,2017-01-01,2017-03-31,2018-04-26 15:22:37+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,0.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2017.0,Q1,2017-01-01,2017-03-31,2018-04-26 15:22:37+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,25224000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2017.0,Q1,2017-01-01,2017-03-31,2018-04-26 15:22:37+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,61578000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2017.0,Q1,2017-01-01,2017-03-31,2018-04-26 15:22:37+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.41
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2017.0,Q1,2017-01-01,2017-03-31,2018-04-26 15:22:37+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,65439000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2017.0,Q1,2017-01-01,2017-03-31,2018-04-26 15:22:37+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.39
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2017.0,Q1,2017-01-01,2017-03-31,2018-04-26 15:22:37+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,61500000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2017.0,Q1,2017-01-01,2017-03-31,2018-04-26 15:22:37+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.41
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 10:28:08+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,533724000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 10:28:08+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,533724000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 10:28:08+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,300611000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 10:28:08+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,300611000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 10:28:08+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,233113000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 10:28:08+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,76195000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 10:28:08+00:00,totaloperatingexpenses,depreciationexpense,Depreciation Expense,+,debit,usd,16101000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 10:28:08+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,75817000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 10:28:08+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,150000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 10:28:08+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,168263000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 10:28:08+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,64850000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 10:28:08+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-10004000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 10:28:08+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-15021000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 10:28:08+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-25025000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 10:28:08+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,39825000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 10:28:08+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,10193000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 10:28:08+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,26000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 10:28:08+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,29658000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 10:28:08+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,29658000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 10:28:08+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,112000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 10:28:08+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,29546000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 10:28:08+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,62232000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 10:28:08+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.47
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 10:28:08+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,65727000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 10:28:08+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.45
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 10:28:08+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,62900000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 10:28:08+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.47
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 13:09:13+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,582009000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 13:09:13+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,582009000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 13:09:13+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,414324000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 13:09:13+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,414324000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 13:09:13+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,167685000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 13:09:13+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,79307000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 13:09:13+00:00,totaloperatingexpenses,depreciationexpense,Depreciation Expense,+,debit,usd,18853000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 13:09:13+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,11741000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 13:09:13+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,8000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 13:09:13+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,109909000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 13:09:13+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,57776000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 13:09:13+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,3089000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 13:09:13+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-11557000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 13:09:13+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-12789000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 13:09:13+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-27435000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 13:09:13+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,30341000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 13:09:13+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-18241000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 13:09:13+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,24000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 13:09:13+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,48606000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 13:09:13+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,48606000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 13:09:13+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,401000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 13:09:13+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,48205000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 13:09:13+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,62730000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 13:09:13+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.77
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 13:09:13+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,65872000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 13:09:13+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.73
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 13:09:13+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,62600000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 13:09:13+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.77
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2017.0,Q4,2017-10-01,2017-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,655896000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2017.0,Q4,2017-10-01,2017-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,655896000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2017.0,Q4,2017-10-01,2017-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,592436000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2017.0,Q4,2017-10-01,2017-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,592436000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,63460000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,92217000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingexpenses,depreciationexpense,Depreciation Expense,+,debit,usd,28081000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,-60569000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,118000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,59847000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2017.0,Q4,2017-10-01,2017-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,3613000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2017.0,Q4,2017-10-01,2017-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,11934000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2017.0,Q4,2017-10-01,2017-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-15641000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2017.0,Q4,2017-10-01,2017-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-4722000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2017.0,Q4,2017-10-01,2017-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-32297000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2017.0,Q4,2017-10-01,2017-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-28684000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2017.0,Q4,2017-10-01,2017-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-12458000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2017.0,Q4,2017-10-01,2017-12-31,,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,31000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2017.0,Q4,2017-10-01,2017-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-16195000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2017.0,Q4,2017-10-01,2017-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-16195000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2017.0,Q4,2017-10-01,2017-12-31,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-147000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2017.0,Q4,2017-10-01,2017-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-16048000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2017.0,Q4,2017-10-01,2017-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,62437000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2017.0,Q4,2017-10-01,2017-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.26
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2017.0,Q4,2017-10-01,2017-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,65773000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2017.0,Q4,2017-10-01,2017-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.25
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2017.0,Q4,2017-10-01,2017-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,62500000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2017.0,Q4,2017-10-01,2017-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.26
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 10:45:25+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,701837000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 10:45:25+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,701837000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 10:45:25+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,522440000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 10:45:25+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,522440000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 10:45:25+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,179397000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 10:45:25+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,91702000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 10:45:25+00:00,totaloperatingexpenses,depreciationexpense,Depreciation Expense,+,debit,usd,27339000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 10:45:25+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,-11578000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 10:45:25+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,-14000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 10:45:25+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,107449000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 10:45:25+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,71948000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 10:45:25+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-14825000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 10:45:25+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-282000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 10:45:25+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-15107000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 10:45:25+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,56841000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 10:45:25+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,17654000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 10:45:25+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,28000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 10:45:25+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,39215000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 10:45:25+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,39215000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 10:45:25+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,234000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 10:45:25+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,38981000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 10:45:25+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,63530000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 10:45:25+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.61
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 10:45:25+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,66161000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 10:45:25+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.59
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 10:45:25+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,63900000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 10:45:25+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.61
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2018.0,Q2,2018-04-01,2018-06-30,2018-08-02 10:28:08+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,722841000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2018.0,Q2,2018-04-01,2018-06-30,2018-08-02 10:28:08+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,722841000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2018.0,Q2,2018-04-01,2018-06-30,2018-08-02 10:28:08+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,381655000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2018.0,Q2,2018-04-01,2018-06-30,2018-08-02 10:28:08+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,381655000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2018.0,Q2,2018-04-01,2018-06-30,2018-08-02 10:28:08+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,341186000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2018.0,Q2,2018-04-01,2018-06-30,2018-08-02 10:28:08+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,91169000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2018.0,Q2,2018-04-01,2018-06-30,2018-08-02 10:28:08+00:00,totaloperatingexpenses,depreciationexpense,Depreciation Expense,+,debit,usd,28554000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2018.0,Q2,2018-04-01,2018-06-30,2018-08-02 10:28:08+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,147617000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2018.0,Q2,2018-04-01,2018-06-30,2018-08-02 10:28:08+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,50000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2018.0,Q2,2018-04-01,2018-06-30,2018-08-02 10:28:08+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,267390000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2018.0,Q2,2018-04-01,2018-06-30,2018-08-02 10:28:08+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,73796000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2018.0,Q2,2018-04-01,2018-06-30,2018-08-02 10:28:08+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-14612000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2018.0,Q2,2018-04-01,2018-06-30,2018-08-02 10:28:08+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,542000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2018.0,Q2,2018-04-01,2018-06-30,2018-08-02 10:28:08+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-14070000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2018.0,Q2,2018-04-01,2018-06-30,2018-08-02 10:28:08+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,59726000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2018.0,Q2,2018-04-01,2018-06-30,2018-08-02 10:28:08+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,17490000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2018.0,Q2,2018-04-01,2018-06-30,2018-08-02 10:28:08+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,46000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2018.0,Q2,2018-04-01,2018-06-30,2018-08-02 10:28:08+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,42282000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2018.0,Q2,2018-04-01,2018-06-30,2018-08-02 10:28:08+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,42282000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2018.0,Q2,2018-04-01,2018-06-30,2018-08-02 10:28:08+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,305000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2018.0,Q2,2018-04-01,2018-06-30,2018-08-02 10:28:08+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,41977000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2018.0,Q2,2018-04-01,2018-06-30,2018-08-02 10:28:08+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,63874000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2018.0,Q2,2018-04-01,2018-06-30,2018-08-02 10:28:08+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.66
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2018.0,Q2,2018-04-01,2018-06-30,2018-08-02 10:28:08+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,66078000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2018.0,Q2,2018-04-01,2018-06-30,2018-08-02 10:28:08+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.64
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2018.0,Q2,2018-04-01,2018-06-30,2018-08-02 10:28:08+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,63600000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2018.0,Q2,2018-04-01,2018-06-30,2018-08-02 10:28:08+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.66
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2018.0,Q3,2018-07-01,2018-09-30,2019-10-31 12:01:58+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,717596000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2018.0,Q3,2018-07-01,2018-09-30,2019-10-31 12:01:58+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,717596000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2018.0,Q3,2018-07-01,2018-09-30,2019-10-31 12:01:58+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,514139000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2018.0,Q3,2018-07-01,2018-09-30,2019-10-31 12:01:58+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,514139000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2018.0,Q3,2018-07-01,2018-09-30,2019-10-31 12:01:58+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,203457000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2018.0,Q3,2018-07-01,2018-09-30,2019-10-31 12:01:58+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,92553000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2018.0,Q3,2018-07-01,2018-09-30,2019-10-31 12:01:58+00:00,totaloperatingexpenses,depreciationexpense,Depreciation Expense,+,debit,usd,28270000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2018.0,Q3,2018-07-01,2018-09-30,2019-10-31 12:01:58+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,43837000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2018.0,Q3,2018-07-01,2018-09-30,2019-10-31 12:01:58+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,-15000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2018.0,Q3,2018-07-01,2018-09-30,2019-10-31 12:01:58+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,164645000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2018.0,Q3,2018-07-01,2018-09-30,2019-10-31 12:01:58+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,38812000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2018.0,Q3,2018-07-01,2018-09-30,2019-10-31 12:01:58+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,454000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2018.0,Q3,2018-07-01,2018-09-30,2019-10-31 12:01:58+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-14423000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2018.0,Q3,2018-07-01,2018-09-30,2019-10-31 12:01:58+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-1877000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2018.0,Q3,2018-07-01,2018-09-30,2019-10-31 12:01:58+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-16754000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2018.0,Q3,2018-07-01,2018-09-30,2019-10-31 12:01:58+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,22058000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2018.0,Q3,2018-07-01,2018-09-30,2019-10-31 12:01:58+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,20248000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2018.0,Q3,2018-07-01,2018-09-30,2019-10-31 12:01:58+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,44000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2018.0,Q3,2018-07-01,2018-09-30,2019-10-31 12:01:58+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1854000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2018.0,Q3,2018-07-01,2018-09-30,2019-10-31 12:01:58+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1854000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2018.0,Q3,2018-07-01,2018-09-30,2019-10-31 12:01:58+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,359000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2018.0,Q3,2018-07-01,2018-09-30,2019-10-31 12:01:58+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1495000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2018.0,Q3,2018-07-01,2018-09-30,2019-10-31 12:01:58+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,64261000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2018.0,Q3,2018-07-01,2018-09-30,2019-10-31 12:01:58+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.02
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2018.0,Q3,2018-07-01,2018-09-30,2019-10-31 12:01:58+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,66506000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2018.0,Q3,2018-07-01,2018-09-30,2019-10-31 12:01:58+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.02
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2018.0,Q3,2018-07-01,2018-09-30,2019-10-31 12:01:58+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,74800000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2018.0,Q3,2018-07-01,2018-09-30,2019-10-31 12:01:58+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.02
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2018.0,Q4,2018-10-01,2018-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,729648000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2018.0,Q4,2018-10-01,2018-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,729648000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2018.0,Q4,2018-10-01,2018-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,652397000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2018.0,Q4,2018-10-01,2018-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,652397000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,77251000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,96371000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingexpenses,depreciationexpense,Depreciation Expense,+,debit,usd,28084000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,-144059000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,99000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,-19505000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2018.0,Q4,2018-10-01,2018-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,96756000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2018.0,Q4,2018-10-01,2018-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,498000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2018.0,Q4,2018-10-01,2018-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-13539000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2018.0,Q4,2018-10-01,2018-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,203000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2018.0,Q4,2018-10-01,2018-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-13834000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2018.0,Q4,2018-10-01,2018-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,82922000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2018.0,Q4,2018-10-01,2018-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,11840000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2018.0,Q4,2018-10-01,2018-12-31,,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,25000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2018.0,Q4,2018-10-01,2018-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,71107000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2018.0,Q4,2018-10-01,2018-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,71107000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2018.0,Q4,2018-10-01,2018-12-31,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-345000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2018.0,Q4,2018-10-01,2018-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,71452000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2018.0,Q4,2018-10-01,2018-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,64123000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2018.0,Q4,2018-10-01,2018-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,1.11
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2018.0,Q4,2018-10-01,2018-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,66341000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2018.0,Q4,2018-10-01,2018-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.07
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2018.0,Q4,2018-10-01,2018-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,64100000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2018.0,Q4,2018-10-01,2018-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.11
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2019.0,Q1,2019-01-01,2019-03-31,2020-05-01 14:19:12+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,722022000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2019.0,Q1,2019-01-01,2019-03-31,2020-05-01 14:19:12+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,722022000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2019.0,Q1,2019-01-01,2019-03-31,2020-05-01 14:19:12+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,518508000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2019.0,Q1,2019-01-01,2019-03-31,2020-05-01 14:19:12+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,518508000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2019.0,Q1,2019-01-01,2019-03-31,2020-05-01 14:19:12+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,203514000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2019.0,Q1,2019-01-01,2019-03-31,2020-05-01 14:19:12+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,97095000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2019.0,Q1,2019-01-01,2019-03-31,2020-05-01 14:19:12+00:00,totaloperatingexpenses,depreciationexpense,Depreciation Expense,+,debit,usd,27608000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2019.0,Q1,2019-01-01,2019-03-31,2020-05-01 14:19:12+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,0.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2019.0,Q1,2019-01-01,2019-03-31,2020-05-01 14:19:12+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,88000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2019.0,Q1,2019-01-01,2019-03-31,2020-05-01 14:19:12+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,124791000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2019.0,Q1,2019-01-01,2019-03-31,2020-05-01 14:19:12+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,78723000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2019.0,Q1,2019-01-01,2019-03-31,2020-05-01 14:19:12+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-12369000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2019.0,Q1,2019-01-01,2019-03-31,2020-05-01 14:19:12+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,6040000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2019.0,Q1,2019-01-01,2019-03-31,2020-05-01 14:19:12+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-6329000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2019.0,Q1,2019-01-01,2019-03-31,2020-05-01 14:19:12+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,72394000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2019.0,Q1,2019-01-01,2019-03-31,2020-05-01 14:19:12+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,28138000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2019.0,Q1,2019-01-01,2019-03-31,2020-05-01 14:19:12+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,44256000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2019.0,Q1,2019-01-01,2019-03-31,2020-05-01 14:19:12+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,44256000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2019.0,Q1,2019-01-01,2019-03-31,2020-05-01 14:19:12+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,172000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2019.0,Q1,2019-01-01,2019-03-31,2020-05-01 14:19:12+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,44084000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2019.0,Q1,2019-01-01,2019-03-31,2020-05-01 14:19:12+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,65192000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2019.0,Q1,2019-01-01,2019-03-31,2020-05-01 14:19:12+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.68
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2019.0,Q1,2019-01-01,2019-03-31,2020-05-01 14:19:12+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,66847000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2019.0,Q1,2019-01-01,2019-03-31,2020-05-01 14:19:12+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.66
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2019.0,Q1,2019-01-01,2019-03-31,2020-05-01 14:19:12+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,64800000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2019.0,Q1,2019-01-01,2019-03-31,2020-05-01 14:19:12+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.68
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2019.0,Q2,2019-04-01,2019-06-30,2019-08-01 11:54:24+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,763309000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2019.0,Q2,2019-04-01,2019-06-30,2019-08-01 11:54:24+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,763309000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2019.0,Q2,2019-04-01,2019-06-30,2019-08-01 11:54:24+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,547346000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2019.0,Q2,2019-04-01,2019-06-30,2019-08-01 11:54:24+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,547346000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2019.0,Q2,2019-04-01,2019-06-30,2019-08-01 11:54:24+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,215963000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2019.0,Q2,2019-04-01,2019-06-30,2019-08-01 11:54:24+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,98804000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2019.0,Q2,2019-04-01,2019-06-30,2019-08-01 11:54:24+00:00,totaloperatingexpenses,depreciationexpense,Depreciation Expense,+,debit,usd,28591000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2019.0,Q2,2019-04-01,2019-06-30,2019-08-01 11:54:24+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,0.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2019.0,Q2,2019-04-01,2019-06-30,2019-08-01 11:54:24+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,555000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2019.0,Q2,2019-04-01,2019-06-30,2019-08-01 11:54:24+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,127950000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2019.0,Q2,2019-04-01,2019-06-30,2019-08-01 11:54:24+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,88013000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2019.0,Q2,2019-04-01,2019-06-30,2019-08-01 11:54:24+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-12491000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2019.0,Q2,2019-04-01,2019-06-30,2019-08-01 11:54:24+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-9663000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2019.0,Q2,2019-04-01,2019-06-30,2019-08-01 11:54:24+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-22154000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2019.0,Q2,2019-04-01,2019-06-30,2019-08-01 11:54:24+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,65859000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2019.0,Q2,2019-04-01,2019-06-30,2019-08-01 11:54:24+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,24804000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2019.0,Q2,2019-04-01,2019-06-30,2019-08-01 11:54:24+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,0.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2019.0,Q2,2019-04-01,2019-06-30,2019-08-01 11:54:24+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,41055000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2019.0,Q2,2019-04-01,2019-06-30,2019-08-01 11:54:24+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,41055000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2019.0,Q2,2019-04-01,2019-06-30,2019-08-01 11:54:24+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-73000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2019.0,Q2,2019-04-01,2019-06-30,2019-08-01 11:54:24+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,41128000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2019.0,Q2,2019-04-01,2019-06-30,2019-08-01 11:54:24+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,65328000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2019.0,Q2,2019-04-01,2019-06-30,2019-08-01 11:54:24+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.63
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2019.0,Q2,2019-04-01,2019-06-30,2019-08-01 11:54:24+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,66763000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2019.0,Q2,2019-04-01,2019-06-30,2019-08-01 11:54:24+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.62
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2019.0,Q2,2019-04-01,2019-06-30,2019-08-01 11:54:24+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,65300000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2019.0,Q2,2019-04-01,2019-06-30,2019-08-01 11:54:24+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.63
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2019.0,Q3,2019-07-01,2019-09-30,2019-10-31 12:01:58+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,780691000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2019.0,Q3,2019-07-01,2019-09-30,2019-10-31 12:01:58+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,780691000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2019.0,Q3,2019-07-01,2019-09-30,2019-10-31 12:01:58+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,559269000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2019.0,Q3,2019-07-01,2019-09-30,2019-10-31 12:01:58+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,559269000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2019.0,Q3,2019-07-01,2019-09-30,2019-10-31 12:01:58+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,221422000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2019.0,Q3,2019-07-01,2019-09-30,2019-10-31 12:01:58+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,95542000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2019.0,Q3,2019-07-01,2019-09-30,2019-10-31 12:01:58+00:00,totaloperatingexpenses,depreciationexpense,Depreciation Expense,+,debit,usd,29264000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2019.0,Q3,2019-07-01,2019-09-30,2019-10-31 12:01:58+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,572000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2019.0,Q3,2019-07-01,2019-09-30,2019-10-31 12:01:58+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,256000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2019.0,Q3,2019-07-01,2019-09-30,2019-10-31 12:01:58+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,125634000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2019.0,Q3,2019-07-01,2019-09-30,2019-10-31 12:01:58+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,95788000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2019.0,Q3,2019-07-01,2019-09-30,2019-10-31 12:01:58+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1855000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2019.0,Q3,2019-07-01,2019-09-30,2019-10-31 12:01:58+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-12974000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2019.0,Q3,2019-07-01,2019-09-30,2019-10-31 12:01:58+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,5423000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2019.0,Q3,2019-07-01,2019-09-30,2019-10-31 12:01:58+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-9406000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2019.0,Q3,2019-07-01,2019-09-30,2019-10-31 12:01:58+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,86382000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2019.0,Q3,2019-07-01,2019-09-30,2019-10-31 12:01:58+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,3375000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2019.0,Q3,2019-07-01,2019-09-30,2019-10-31 12:01:58+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,0.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2019.0,Q3,2019-07-01,2019-09-30,2019-10-31 12:01:58+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,83007000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2019.0,Q3,2019-07-01,2019-09-30,2019-10-31 12:01:58+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,83007000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2019.0,Q3,2019-07-01,2019-09-30,2019-10-31 12:01:58+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,0.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2019.0,Q3,2019-07-01,2019-09-30,2019-10-31 12:01:58+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,83007000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2019.0,Q3,2019-07-01,2019-09-30,2019-10-31 12:01:58+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,64771000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2019.0,Q3,2019-07-01,2019-09-30,2019-10-31 12:01:58+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,1.28
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2019.0,Q3,2019-07-01,2019-09-30,2019-10-31 12:01:58+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,66213000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2019.0,Q3,2019-07-01,2019-09-30,2019-10-31 12:01:58+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.25
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2019.0,Q3,2019-07-01,2019-09-30,2019-10-31 12:01:58+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,64800000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2019.0,Q3,2019-07-01,2019-09-30,2019-10-31 12:01:58+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.28
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2019.0,Q4,2019-10-01,2019-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,800240000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2019.0,Q4,2019-10-01,2019-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,800240000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2019.0,Q4,2019-10-01,2019-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,564498000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2019.0,Q4,2019-10-01,2019-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,564498000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,235742000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,103484000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingexpenses,depreciationexpense,Depreciation Expense,+,debit,usd,29435000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,1263000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,159000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,134341000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2019.0,Q4,2019-10-01,2019-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,101401000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2019.0,Q4,2019-10-01,2019-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,2073000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2019.0,Q4,2019-10-01,2019-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-14153000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2019.0,Q4,2019-10-01,2019-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-3883000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2019.0,Q4,2019-10-01,2019-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-20109000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2019.0,Q4,2019-10-01,2019-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,81292000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2019.0,Q4,2019-10-01,2019-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,6491000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2019.0,Q4,2019-10-01,2019-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,74801000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2019.0,Q4,2019-10-01,2019-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,74801000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2019.0,Q4,2019-10-01,2019-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,74801000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2019.0,Q4,2019-10-01,2019-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,64506000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2019.0,Q4,2019-10-01,2019-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,1.18
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2019.0,Q4,2019-10-01,2019-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,66004000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2019.0,Q4,2019-10-01,2019-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.15
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2019.0,Q4,2019-10-01,2019-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,64500000.0
PRA Health Sciences Inc,PRAH,549300R1HR1VWWHIAK47,0001613859,2019.0,Q4,2019-10-01,2019-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.18
